Oral anticoagulant monotherapy in patients with chronic coronary disease: An updated meta-analysis
In patients with chronic coronary disease requiring long-term anticoagulation, OAC monotherapy reduces bleeding complications without increasing the risk of ischemic events compared to dual therapy. These findings support the use of a simplified antithrombotic strategy without antiplatelet therapy in this patient population.
Authors
- Mushood Ahmed (ORCID: https://orcid.org/0000-0001-9872-8224)
- Jamal S. Rana (ORCID: https://orcid.org/0000-0002-8222-3958)
- Gregg C. Fonarow (ORCID: https://orcid.org/0000-0002-3192-8093)
Institutions
- Kaiser Permanente (US)
- Rawalpindi Medical University (PK)
- UCLA Health (US)
- University of Newcastle Australia (AU)
- Newcastle University (GB)
Publication Details
- Journal
- The American Journal of Medicine
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1016/j.amjmed.2025.09.019
- Citations
- 2
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.78